Resistance to glomerulosclerosis in B6 mice disappears after menopause

American Journal of Pathology

Volumn 162, Issue 4, 2003, Pages 1339-1348

  Zheng, Feng ^a   Plati, Anna Rita ^a   Potier, Mylene ^a   Schulman, Yvonne ^a   Berho, Mariana ^a   Banerjee, Anita ^a   Leclercq, Baudouin ^a   Zisman, Ariel ^a   Striker, Liliane J ^a   Striker, Gary E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; GLUCOSE; INSULIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL ISOLATION; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HISTOPATHOLOGY; HYPERTROPHY; IN VITRO STUDY; INSULIN TOLERANCE TEST; KIDNEY FAILURE; KIDNEY FUNCTION; MENOPAUSE; MESANGIUM CELL; MOUSE; NEPHRECTOMY; NONHUMAN; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEINURIA; URINARY EXCRETION;

EID: 0037378556     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63929-6     Document Type: Article

References (42)

1. Berthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D: Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 1999, 14:2332-2342
2. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 2001, 161:1207-1216
3. U. S. Renal Data System: USRDS 1999 annual data report. The National Institutes of Health, NIDDK 1999
4. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ: Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997, 278:2069-2074
5. Striker GE: Kidney disease and hypertension in blacks. Am J Kidney Dis 1992, 20:673
6. Muhlberg W, Platt D: Age-dependent changes of the kidneys: pharmacological implications. Gerontology 1999, 45:243-253
7. Striker GE, Nagle RB, Kohnen PW, Smuckler EA: Response to unilateral nephrectomy in old rats. Arch Pathol 1969, 87:439-442
8. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J: End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997, 277:1293-1298
9. Hackbarth H, Harrison DE: Changes with age in renal function and morphology in C57BL/6, CBA/HT6, and B6CBAF1 mice J Gerontol 1982, 37:540-547
10. Anderson S, Brenner BM: Effects of aging on the renal glomerulus. Am J Med 1986, 80:435-442
11. Ruiz-Torres P, Lucio J, Gonzalez-Rubio M, Rodriguez-Puyol M, Rodriguez-Puyol D: Oxidant/antioxidant balance in isolated glomeruli and cultured mesangial cells. Free Radic Biol Med 1997, 22:49-56
12. Baylis C: Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy male gender as a primary risk factor. J Clin Invest 1994, 94:1823-1829
13. Vlassara H, Bucala R, Striker L: Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994, 70:138-151
14. Esposito C, He CJ, Striker GE, Zalups RK, Striker LJ: Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice Am J Pathol 1999, 154:891-897
15. He C, Esposito C, Phillips C, Zalups RK, Henderson DA, Striker GE, Striker LJ: Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 1996, 97:1242-1249
16. Zheng F, Striker GE, Esposito C, Lupia E, Striker LJ: Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 1998, 54:1999-2007
17. Nelson JF, Felicio LS, Randall PK, Sims C, Finch CE: A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod 1982, 27:327-339
18. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 1994, 91:9436-9440
19. Doi T, Striker LJ, Gibson CC, Agodoa LY, Brinster RL, Striker GE: Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 1990, 137:541-552
20. Yang CW, Striker LJ, Pesce C, Chen WY, Peten EP, Elliot S, Doi T, Kopchick JJ, Striker GE: Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Studies in transgenic mice. Lab Invest 1993, 68:62-70
21. DeHoff RT, Rhines FN: Method of estimating size of discrete objects. Quantitative Microscopy. Edited by RT DeHoff and FN Rhines. New York, McGraw-Hill, 1968, pp 75
22. Peten EP, Garcia-Perez A, Terada Y, Woodrow D, Martin BM, Striker GE, Striker LJ: Age-related changes in α1- and α2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR. Am J Physiol 1992, 263:F951-F957
23. Potier M, Karl M, Zheng F, Elliot SJ, Striker GE, Striker LJ: Estrogen-related abnormalities in glomerurosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol 2002, 160:1877-1885
24. Jacot TA, Striker GE, Stetler-Stevenson M, Striker LJ: Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen. Lab Invest 1996, 75:791-799
25. Zheng F, Fornoni A, Elliot SJ, Guan Y, Breyer MD, Striker LJ, Striker GE: Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation. Am J Physiol Renal Physiol 2002, 282:F639-F648
26. Poncelet AC, Schnaper HW: Spl and Smad proteins cooperate to mediate transforming growth factor-β 1-induced α2 (I) collagen expression in human glomerular mesangial cells. J Biol Chem 2001, 276:6983-6992
27. Baylis C, Schmidt R: The aging glomerulus. Semin Nephrol 1996, 16:265-276
28. Yumura W, Sugino N, Nagasawa R, Kubo S, Hirokawa K, Maruyama N: Age-associated changes in renal glomeruli of mice. Exp Gerontol 1989, 24:237-249
29. Fogo A, Ichikawa I: Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 1991, 17:666-669
30. MacKay K, Striker LJ, Stauffer JW, Agodoa LY, Striker GE: Relationship of glomerular hypertrophy and sclerosis: studies in SV40 transgenic mice. Kidney Int 1990, 37:741-748
31. Davies I, Fotheringham AP, Faragher BE: Age-associated changes in the kidney of the laboratory mouse. Age Ageing 1989, 18:127-133
32. Potier M, Erliot SJ, Tack I, Lenz O, Striker GE, Striker LJ, Karl M: Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001, 12:241-251
33. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE: The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol 1992, 2: S190-S197
34. Schocklmann HO, Lang S, Sterzel RB: Regulation of mesangial cell proliferation. Kidney Int 1999, 56:1199-1207
35. Cornacchia F, Fornoni A, Plati AR, Thomas A, Wang Y, Inverardi L, Striker LJ, Striker GE: Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest 2001, 108: 1649-1656
36. Lupia E, Elliot, SJ, Lenz O, Zheng F, Hattori M, Striker GE, Striker LJ: IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes 1999, 48:1638-1644
37. Fornoni A, Striker LJ, Zheng F, Striker GE: Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background. Diabetes 2002, 51:499-505
38. Elliot SJ, Striker LJ, Hattori M, Yang CW, He CJ, Peten EP, Striker GE: Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I. Endocrinology 1993, 133:1783-1788
39. Poncelet AC, Schnaper HW: Regulation of human mesangial cell collagen expression by transforming growth factor-β1 Am J Physiol 1998, 275:F458-F466
40. Ketteler M, Noble NA, Border WA: Increased expression of transforming growth factor-β in renal disease. Curr Opin Nephrol Hypertens 1994, 3:446-452
41. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN: Extracellular signal-regulated kinase mediates stimulation of TGF-/31 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 2000, 11:2222-2230
42. Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB: Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 2000, 58:2425-2436